CClinicalTrials.gg
CompletedNCT03405506FORTRESSUpdated Jun 3, 2025

Functional Diagnostic Accuracy of Quantitative Flow Ratio in Tandem Lesions and Virtual Stenting

An observational study in Coronary Artery Disease, Cardiovascular Diseases and Myocardial Ischemia, sponsored by Pulse Medical Imaging Technology (Shanghai) Co., Ltd. Completed at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-03.

Sponsored by Pulse Medical Imaging Technology (Shanghai) Co., Ltd · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
308
Ages
18 Years and older
Sex
All
01

Study summary

Quantitative Flow Ratio (QFR) is a novel method for evaluating the functional significance of coronary stenosis. Virtual stent implantation technique combined with QFR was recently developed to predict the functional significance of coronary stenosis as if the stenosis was revascularized.

The purpose of this study is to evaluate the diagnostic accuracy of QFR in in tandem lesions with fractional flow reserve (FFR) as the reference standard. The secondary purpose is to evaluate the diagnostic accuracy of QFR-based virtual stent technique in predicting the FFR values after revascularizing the culprit lesion.

Read the detailed description

QFR is a novel method for evaluating the functional significance of coronary stenosis by calculation of the pressure drop in the vessel. 3D coronary models can be reconstructed based on two angiographic projections to obtain the geometric parameters, including vascular diameter or cross-sectional area. According to the lesion stenosis, vessel curvature, conical geometry and reference lumen characteristics, pressure drop can be calculated in real time based on its relationship with blood flow. There is no need for pressure wire and adenosine / ATP induced maximum hyperemia compared with FFR.

The FAVOR Pilot Study and FAVOR II China Study showed promising results for diagnostic accuracy in consecutive patients. However, the diagnostic accuracy of QFR in specific tandem lesions needs further investigation. Furthermore, using the virtual stent technology to accurately assess the culprit lesion and choose the optimal treatment is significant in precisely guiding PCI surgery.

02

Conditions studied

  • Coronary Artery Disease
  • Cardiovascular Diseases
  • Myocardial Ischemia
  • Arterial Occlusive Diseases
  • Heart Diseases
  • Vascular Diseases
  • Arteriosclerosis

Keywords

  • Fractional Flow Reserve
  • Quantitative Coronary Angiography
  • Coronary artery disease
  • Quantitative Flow Ratio
  • Tandem lesion
  • Virtual stenting
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with coronary tandem lesions admitted for coronary angiography due to high risk of significant coronary stenosis

Inclusion criteria

  • General inclusion Criteria:

    1. Stable and unstable angina pectoris or secondary evaluation of stenosis after acute MI;
    2. Age > 18 years;
    3. Able to provide signed informed consent.
  • Angiographic inclusion criteria:

    1. At least two localized lesions on the same coronary artery;
    2. More than 50% diameter stenosis (DS) estimated by QCA on each lesion;
    3. At least 10 mm relatively normal lumen (at most 20% DS) between two lesions;
    4. Reference vessel size > 2 mm in stenotic segment by visual estimate.

Exclusion criteria

Exclusion Criteria:

  • General exclusion criteria:

    1. Ineligible for diagnostic intervention or FFR examination;
    2. Myocardial infarction within 72 hours;
    3. Severe heart failure (NYHA≥III);
    4. S-creatinine>150µmol/L or GFR\<45 ml/kg/1.73m2;
    5. Allergy to contrast agent or adenosine;
    6. Factors that might substantially impact the angiographic image quality, e.g, frequent atrial premature beat or atrial fibrillation;
    7. Serious complications:

      1. Evidence of cardiac rupture;
      2. History of bleeding (intracranial hemorrhage, gastrointestinal bleeding, etc.);
      3. Acute or chronic blood system diseases, including hemoglobin \< 10 g / L, or platelet count \< 50 × 109 / L;
      4. Accompanied by other diseases might inducing life expectancy shorter than several months;
      5. History of severe renal insufficiency and hypohepatia (liver failure, cirrhosis, portal hypertension and active hepatitis)
      6. Aneurysm, arterial / venous malformation, aortic dissection;
    8. Cardiogenic shock or circulation capacity failure;
    9. Two-degree and more severe atrioventricular block, with no permanent pacemaker implanted;
    10. Pregnancy or lactation;
    11. The investigators believe that the treatment regimen may be detrimental to the patient or the enrollment of this subject may affect the specific assessment of the trial;
  • Angiographic exclusion criteria:

    1. The interrogated stenosis is caused by myocardial bridge;
    2. Ostial lesions less than 3 mm to the aorta;
    3. Side branches of the bifurcation lesions with Median Classification of 111 or 101;
    4. Severe overlap or shorten of stenosis segment;
    5. Severe tortuosity of target vessel;
    6. Poor angiographic image quality precluding contour detection.
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
308 participants (actual)
Target follow-up
1 Year
Patient registry
Yes

Interventions

  • DeviceQuantitative Flow Ratio (QFR)

    FFR measured by pressure wire, QFR computed by coronary angiographic images

05

What researchers measure

Primary outcomes

  1. Diagnostic accuracy of QFR in tandem lesions as compared with FFR prior to intervention

    Diagnostic accuracy was defined as the concordance ratio of QFR evaluated outcomes (≤ 0.8 or \> 0.8) with the reference standard FFR evaluated outcomes (≤ 0.8 or \> 0.8)

    Time frame: 1 hour

Secondary outcomes

  1. Diagnostic accuracy of QFR-based virtual stenting in predicting FFR values after revascularizing the culprit lesion

    Diagnostic accuracy was defined as the concordance ratio of QFR evaluated outcomes (≤ 0.8 or \> 0.8) with the reference standard FFR evaluated outcomes (≤ 0.8 or \> 0.8)

    Time frame: 1 hour

06

Study locations

1 site
  • Huadong Hospital affiliated to Fudan University
    Shanghai, Shanghai 200040, China
07

References and documents

Publications

  • Tu S, Westra J, Yang J, von Birgelen C, Ferrara A, Pellicano M, Nef H, Tebaldi M, Murasato Y, Lansky A, Barbato E, van der Heijden LC, Reiber JHC, Holm NR, Wijns W; FAVOR Pilot Trial Study Group. Diagnostic Accuracy of Fast Computational Approaches to Derive Fractional Flow Reserve From Diagnostic Coronary Angiography: The International Multicenter FAVOR Pilot Study. JACC Cardiovasc Interv. 2016 Oct 10;9(19):2024-2035. doi: 10.1016/j.jcin.2016.07.013. PubMed 27712739 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT03405506
Lead sponsor
Pulse Medical Imaging Technology (Shanghai) Co., Ltd
Collaborators
Shanghai Chest Hospital
Responsible party
Sponsor
First posted
Jan 23, 2018
Start date
Jun 13, 2017
Primary completion
Jul 20, 2017
Completion
Jul 20, 2017
Last update
Jun 3, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion